Knight Therapeutics to Discuss Year-End Results for 2024

Author: Ryan Hughes Updated: 03-13-2025 07:49 AM

Upcoming Conference Call for Year-End Financial Results

Knight Therapeutics Inc. (TSX: GUD), a well-regarded specialty pharmaceutical company with a focus on the Americas (excluding the USA), is gearing up to unveil its fourth quarter and year-end financial results for the year 2024 on an exciting upcoming date.

Date and Time of the Conference Call

The announcement is set to be made public on a Thursday, and all market participants and stakeholders are invited to join in the discussion. The company aims to create an opportunity for everyone to hear the latest on their financial performance.

Details of the Conference Call

This eagerly anticipated event will take place at 8:30 a.m. ET. For those wishing to participate, the call can be accessed via telephone. Interested parties can dial in toll-free or through international lines, as outlined by the company.

Accessing the Live Webcast

In addition to the phone call, the conference will also be available as an audio webcast. This allows attendees to follow along conveniently from their devices, making it easy to stay informed.

Replay Availability

Can't make it to the live session? No worries! Knight Therapeutics has arranged to offer an archived replay of this webcast, which will be accessible for a period of 30 days following the event. This ensures that even those with busy schedules will have an opportunity to catch up on the important developments at Knight.

What to Expect from Knight Therapeutics

As a robust player in the specialty pharmaceutical field, Knight Therapeutics continues to focus on acquiring and commercializing pharmaceutical products tailored for the Canadian and Latin American markets. Their strategic positioning is supported by subsidiaries operating under the names United Medical, Biotoscana Farma, and Laboratorio LKM.

Company Contact Information

For any inquiries related to the upcoming conference call or the company in general, stakeholders can reach out directly to Knight Therapeutics' dedicated investor relations team. Samira Sakhia, the President and Chief Executive Officer, alongside Arvind Utchanah, Chief Financial Officer, are key contacts for the public.

Frequently Asked Questions

When is the conference call scheduled?

The conference call is scheduled for Thursday morning at 8:30 a.m. ET.

How can I access the live audio webcast?

The live audio webcast can be accessed through the company's official website, where it will be streamed for all participants.

Will there be a replay of the conference call?

Yes, an archived replay will be available on the company's website for 30 days after the event.

Where can I find more information about Knight Therapeutics?

More information can be found on Knight Therapeutics' official website and their corporate communications.

Who can I contact for investor-related questions?

For investor inquiries, you can contact Samira Sakhia or Arvind Utchanah at Knight Therapeutics directly via phone or email.

About The Author

Hello, my name is Ryan Hughes. I am a financial, economics, and stock market specialist committed to assisting people in negotiating the intricacies of the financial system. Having a great deal of experience and a thorough grasp of market dynamics and economic trends, my area of expertise is converting complex financial ideas into understandable, practical knowledge. By use of my articles and blog entries, I hope to give you the information and assurance you need to make wise financial choices.

I've had the honor of interacting with a wide range of readers as a writer for several financial blogs, from new investors to seasoned market participants. To enable you to reach your financial goals, I want to make finance, economics, and stock market trends understandable and approachable. I appreciate you traveling with me toward success and financial literacy.

Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.